Company intelligence / Profile preview
Veloce BioPharma
- Ownership
- Private
- Employees
- ~10
- Development stage
- Phase 2
Overview
Veloce BioPharma is a private clinical-stage biopharmaceutical company developing novel povidone‑iodine–based topical drugs for dermatological and ophthalmological conditions. Lead programs have completed or are in Phase II trials for molluscum contagiosum, warts, and chemotherapy-associated paronychia. The company’s Halodine® antiseptics demonstrated rapid viricidal efficacy against SARS-CoV‑2 in preclinical studies but no commercial launches have been reported yet. Clinical results from recent trials have not been publicly disclosed as of early 2025.
- Therapeutic areas
- OncologyDermatologyInfectious Diseases
- Modalities
- Topical small molecules (notably povidone-iodine formulations)
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Veloce BioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Veloce BioPharma.